Clinical Trial

Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma

Name: Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma — clinical trial record (NCT05080010)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine the effect of 3 cycles of chemotherapy(CEV) in the treatment of Stage I enucleated retinoblastoma.

Trial Details

NCT Number	NCT05080010
Lead Sponsor	Sun Yat-sen University
Conditions	Retinoblastoma
Enrollment	500 participants
Start Date	2020-11-01
Primary Completion	2030-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2021-10-15